Expression and functions of EGF, FGF and TGFβ-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells

International Journal of Cancer

Volumn 71, Issue 2, 1997, Pages 284-291

  De Boer, Willem T ^a,c   Houtsmuller, Adriaan B ^b   Izadifar, Vali ^a   Muscatelli Groux, Béatrice ^a   Van Der Kwast, Theodorus H ^b   Chopin, Dominique K ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; NEU DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER INVASION; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSITIONAL CELL CARCINOMA;

ANIMALS; BIOLOGICAL MARKERS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0030970688     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970410)71:2<284::AID-IJC25>3.0.CO;2-G     Document Type: Article

References (36)

1. CARRAWAY, K.L. III and CANTLEY, L.C., A Neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell, 78, 5-8 (1994).
2. CHIRGWIN, J.M., PRZYBYLA, A.E., MACDONALD, R.J. and RUTTER, W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 8, 5294-5299 (1979).
3. CHOPIN, D.K., CARUELLE, J.-P., COLOMBEL, M., PALCY, S., RAVERY, V., CARUELLE, D., ABBOU, C.C. and BARRITAULT, D., Increased immunodetection of acidic fibroblast growth factor in bladder cancer. J. Urol., 150, 1126-1130 (1993).
4. CILENTO, B.G., FREEMAN, M.R., SCHNECK, F.X., RETIK, A.B. and ATALA, A., Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J. Urol., 152, 665-670 (1994).
5. COOMBS, L.M., PIGOTT, D.A., EYDMANN, M.E., PROCTOR, A.J. and KNOWLES, M.A., Reduced expression of TGFβ is associated with advanced disease in transitional-cell carcinoma. Brit. J. Cancer, 67, 578-584 (1993).
6. DANILENKO, D.M., RING, B.D., LU, J.Z., TARPLEY, J.E., CHANG, D., LIU, N., WEN, D. and PIERCE, G.F., Neu differentiation factor up-regulates epidermal migration and integrin expression in excisional wounds. J. clin. Invest., 95, 842-851 (1995).
7. DE BOER, W.I., REBEL, J.M.J., FOEKENS, J.A., VERMEY, M. and VAN DER KWAST, T.H., Characterization of mouse urothelial cell lines in different phases of transitional-cell carcinogenesis. Int. J. Cancer, 54, 1022-1027 (1993).
8. DE BOER, W.I., REBEL, J.M.J., VERMEIJ, M., DE JONG, A.A.W. and VAN DER KWAST, T.H., Characterization of distinct functions for growth factors in murine transitional epithelial cells in primary organotypic culture. Exp. Cell Res., 214, 510-518 (1994).
9. DE BOER, W.I., VERMEIJ, M., GIL DIEZ DE MEDINA, S., BINDELS, E., RADVANYI, F., VAN DER KWAST, T. and CHOPIN, D., Functions of fibroblast and transforming growth factors in primary organoid-like cultures of normal human urothelium. Lab. Invest., 75, 147-156 (1996).
10. DI MARCO, E., PIERCE, J.H., FLEMING, T.P., KRAUS, M.H., MOLLOY, C.J., AARONSON, S.A. and DI FIORE, P.P., Autocrine interaction between TGFα and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene, 4, 831-838 (1989).
11. JOHNSON, G.R., SAEKI, T., GORDON, A.W., SHOYAB, M., SALOMON, D.S. and STROMBERG, K., Autocrine action of amphiregulin in a colon-carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J. Cell Biol., 118, 741-751 (1992).
12. 1 in human prostate cancer cells. Cancer Res., 56, 44-48 (1996).
13. KIMBALL, E.S., BOHN, W.H., COCKLEY, K.D., WARREN, T.C. and SHERWIN, S.A., Distinct high-performance-liquid-chromatography pattern of transforming-growth-factor activity in urine of cancer patients as compared with that of normal individuals. Cancer Res., 44, 3616-3619 (1984).
14. LAU, J.L.T., FOWLER, J.E. and GHOSH, L., Epidermal growth factor in the normal and neoplastic kidney and bladder. J. Urol., 139, 170-175 (1988).
15. LEE, H.-Y., KIM, D.H., CHUNG, M.T., CHANG, J.H., ROBERTS, A.B. and KIM, S.-J., Characterization of genetic changes in transforming-growth-factor-β(TGF-β)-type-I and -type-II receptor in human gastric-cancer cell lines. In Editors Allan Balmain, Curtis C. Harris, and Kenneth Olden, Cancer susceptibility genes and molecular carcinogenesis. A special conference of the American Association for Cancer Research. Keystone, AACR publication Philadelphia, PA, USA, (1996).
16. LEJEUNE, S., LEEK, R., HORAK, E., PLOWMAN, G., GREENALL, M. and HARRIS, A.L., Amphiregulin, epidermal-growth-factor-receptor and estrogen-receptor expression in human primary breast cancer. Cancer Res., 53, 3597-3602 (1993).
17. LEMOINE, N.R., BARNES, D.M., HOLLYWOOD, D.P., HUGHES, C.M., SMITH, P., DUBLIN, E., PRIGENT, S.A., GULLICK, W.J. and HURST, H.C., Expression of the ERBB3 gene product in breast cancer. Brit. J. Cancer, 66, 1116-1121 (1992).
18. MARIKOVSKY, M., LAVI, S., PINKAS-KRAMARSKI, R., KARUNAGARAN, D., LIU, N., WEN, D. and YARDEN, Y., ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene, 10, 1403-1411 (1995).
19. MESSING, E.M., HANSON, P., ULRICH, P. and ERTURK, E., Epidermal-growth-factor interactions with normal and malignant urothelium: in vivo and in situ studies. J. Urol., 138, 1329-1335 (1987).
20. MIYAMOTO, H., KUBOTA, Y. SHUIN, T., TORIGUE, S., DOBASHI, Y. and HOSAKA, M., Expression of transforming growth factor-beta 1 in human bladder cancer. Cancer, 75, 2565-2570 (1995).
21. MYDLO, J.H., MICHAELI, J., CORDON-CARDO, C., GOLDENBERG, A.S., HESTON, W.D.W. and FAIR, W.R., Expression of transforming growth-factor-alpha and epidermal-growth-factor-receptor messenger RNA in neoplastic and non-neoplastic human kidney tissue. Cancer Res., 49, 3407-3411 (1989).
22. MYEROFF, L.L. and 16 OTHERS, A transforming-growth-factor-β-receptor-type-II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55, 5545-5547 (1995).
23. NEAL, D.E., SHARPLES, L., SMITH, K., FENELLY, J., HALL, R.R. and HARRIS, A.L., The epidermal-growth-factor receptor and the prognosis of bladder cancer. Cancer, 65, 1619-1625 (1990).
24. NGUYEN, H.O., DANILENKO, D.M., BUCAY, N., DEROSE, M.L., VAN, G.Y., THOMASON, A. and SIMONET, W.S., Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformation. In: Editors Allan Balmain, Curtis C. Harris and Kennth Olden, Cancer susceptibility genes and molecular carcinogenesis. A special conference of the American Association for Cancer Research, Keystone, (1996).
25. PIEPKORN, M., LO, C. and PLOWMAN, G., Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J. Cell Physiol., 159, 114-120 (1994).
26. erbB4, a fourth member of the epidermal-growth-factor-receptor family. Proc. nat. Acad. Sci. (Wash.), 90, 1746-1750 (1993).
27. PLOWMAN, G.D., GREEN, J.M., MCDONALD, V.L., NEUBAUER, M.G., DISTECHE, C.M., TODARO, G.J. and SHOYAB, M., The amphiregulin gene encodes a novel epidermal-growth-factor-related protein with tumor-inhibitory activity. Mol. cell. Biol., 10, 1969-1981 (1990).
28. RAJKUMAR, T., STAMP, G.W.H., PANDHA, H.S., WAXMAN, J. and GULLICK, W.J., Expression of the type-I-tyrosine-kinase-growth-factor receptors EGF receptor. c-erbB2 and c-erbB3 in bladder cancer. J. Pathol., 179, 381-385 (1996).
29. SALOMON, D.S., NORMANNO, N., CIARDELLO, F., BRANDT, R., SHOYAB, M. and TODARO, G.J., The role of amphiregulin in breast cancer. Breast Cancer Res. Treat., 33, 103-114 (1995).
30. SHINTANI, S., FUNAYAMA, T., YOSHIHAMA, Y., ALCALDE, R.E. and MATSUMURA, T., Prognostic significance of ERBB3 over-expression in oral squamous-cell carcinoma. Cancer Lett., 95, 79-83 (1995).
31. TUCKER, G.C., DELOUVÉE, A., JOUANNEAU, J., GAVRILOVIC, J., MOENS, G., VALLÉS, A.M. and THIERY, J.P., Amplification of invasiveness in organo-typic cultures after NBT-II-rat-bldder-carcinoma stimulation with in vitro scattering factors. Invasion Metastasis, 11, 297-309 (1991).
32. VALLÉS, A.M., BOYER, B., BADET, J., TUCKER, G.C., BARRITAULT, D. and THIERY, J.P., Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder-carcinoma cell line. Proc. nat. Acad. Sci. (Wash.), 87, 1124-1128 (1990).
33. WU, X.-R., MANABE, M., YU, J. and SUN, T.T., Large-scale purification and immunolocalization of bovine uroplakins I. II and III. J. biol. Chem., 265, 19170-19179 (1990).
34. YANG, Y., SPITZER, E., MEYER, D., SACHS, M., NIEMANN, C. HARTMANN, G., WEIDNER, K.M., BIRCHMEIER, C. and BIRCHMEIER, W., Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol., 131, 215-226 (1995).
35. YI, E.S., SHABAIK, A.S., LACEY, D.L., BEDOYA, A.A., YIN, S., HOUSLEY, R.M., DANILENKO, D.M., BENSON, W., COHEN, A.M., PIERCE, G.F., THOMASON, A. and ULICH, T.R., Keratinocyte growth factor causes proliferation of urothelium in vivo. J. Urol., 154, 1556-1570 (1995).
36. YOSHIDA, K., KYO, E., TSUDA, T., TSUIJINO, T., ITO, M., NIMOTO, M. and TAHARA, E., EGF and TGF-α, the ligands of hyperproduced EGFR in human esophageal-carcinoma cells, act as autocrine growth factors. Int. J. Cancer, 45, 131-135 (1990).